A lawsuit has been filed in the Xarelto Multidistrict Litigation (MDL No. 2592) by a man who alleges that Xarelto caused the wrongful death of his father.
The plaintiff in this particular case (2:15-cv-00886) seeks to recover monetary, compensatory and punitive damages incurred from injuries suffered as a result of Xarelto.
The plaintiff’s father, who was prescribed Xarelto by his healthcare provider for the treatment of atrial fibrillation, died in March of 2013 due to a major internal bleed.
Like several other Xarelto complaints filed thus far, this case alleges that defendants Bayer AG and Janssen Pharmaceuticals failed to perform sufficient safety testing on their prescription drug.
Furthermore, the lawsuit claims that these drug companies acted negligently by putting forth misleading advertisements about Xarelto and by failing to warn consumers about significant dangers associated with the drug which they had known about.
The plaintiff asserts that his father would not have taken Xarelto had he been made aware of the significant risks associated with the drug.
Xarelto: Is It A Dangerous Drug?
Xarelto (rivaroxaban) is a blood thinner drug which is often prescribed to reduce the risk of stroke and systemic embolism in patients with atrial fibrillation.
The blood-thinning medication is also commonly prescribed for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
Xarelto is part of a new class of blood thinners known as Novel Oral Anticoagulants (NOACs), which have had commercial success in the US market in recent years.
However, revealing studies have linked the blockbuster drug to potentially harmful side effects including irreversible internal bleeding.
A growing number of lawsuits have now been filed in relation to these allegedly dangerous side effects.
In fact, there are now more than 400 complaints which have been consolidated in the Xarelto MDL based in the US District Court for the Eastern District of Louisiana.
“We expect the number of cases involved in the MDL to continue to grow at a rapid pace as more and more people learn about the studies linking Xarelto to dangerous side effects,” commented Stephen A. Sheller, Esq. who represents plaintiffs in Xarelto lawsuits.
For more information about this article or Xarelto litigation, please contact Marc Goldich at (866) 425-8902.